$0.64
Closed
-(-)

At close

Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply

About

China Pharma Holdings, Inc. engages in the development, manufacture, and marketing of pharmaceutical products. The company is headquartered in Haikou, Hainan and currently employs 215 full-time employees. The company went IPO on 2000-02-15. The firm is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for high-incidence and high-mortality diseases and medical conditions prevalent in the PRC. The firm's products include dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The firm's products and solutions are mainly applied in the treatment of various diseases and medical conditions. The firm mainly operates in the domestic market.
Country

CN

CEO

Ms. Zhilin Li

IPO date

2000

Employees

224

ISIN

US16941T4013

Key stats

Open

$0.64

Volume

52.59K

Market cap

$27.56M

Prev. close

$0.64

Impl / hst vl

-

Open interest

$0.00

$0.64

Day’s Range

$0.64

$0.38

52W Range

$1.73

Valuation

27
Valuation score
Overvalued
P/E
-
P/S
6.88
P/B
0.74
Current ratio
0.28
Debt / Equity
0.09
ROE
-19.02%
Gross margin
29.03%
Income growth
-6.46%
FCF growth
-137.82

Analysts estimates

Earnings

Q1 ‘26 revenue
$983.50K
Q1 ‘26 net income
-$1.14M
Revenue
Net income
Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply